Treating cancer with phosphatidylinositol-3-kinase inhibitors: increasing efficacy and overcoming resistance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treating cancer with phosphatidylinositol-3-kinase inhibitors: increasing efficacy and overcoming resistance

Published:2019-04 Issue:4 Volume:60 Page:747-752
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

Paddock Marcia N.,Field Seth J.,Cantley Lewis C.

Funder

National Institutes of Health

National Cancer Institute

Burroughs Wellcome Fund

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference34 articles.

1. PI3K-C2gamma is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling;Braccini;Nat. Commun.,2015

2. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate;Franke;Science.,1997

3. Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate;Whitman;Nature.,1988

4. Phosphoinositide conversion in endocytosis and the endolysosomal system;Wallroth;J. Biol. Chem.,2018

5. SH2 domains recognize specific phosphopeptide sequences;Songyang;Cell.,1993

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural insights into the interaction of three Y-shaped ligands with PI3Kα;Proceedings of the National Academy of Sciences;2023-08-16

2. Subtype-selective induction of apoptosis in translocation-related sarcoma cells induced by PUMA and BIM upon treatment with pan-PI3K inhibitors;Cell Death & Disease;2023-02-27

3. Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges;Biomedicines;2023-01-01

4. Cryo-EM structures of cancer-specific helical and kinase domain mutations of PI3Kα;Proceedings of the National Academy of Sciences;2022-11-07

5. Nanobodies and chemical cross-links advance the structural and functional analysis of PI3Kα;Proceedings of the National Academy of Sciences;2022-09-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3